Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.
作者信息
Groulx Stéphane, Limburg Heather, Doull Marion, Klarenbach Scott, Singh Harminder, Wilson Brenda J, Thombs Brett
机构信息
Department of Community Health Sciences (Groulx), University of Sherbrooke, Sherbrooke, Que.; Public Health Agency of Canada (Limburg, Doull), Ottawa, Ont.; Department of Medicine (Klarenbach), University of Alberta, Edmonton, Alta.; Internal Medicine and Community Health Sciences (Singh), University of Manitoba, Winnipeg, Man.; Community Health and Humanities (Wilson), Memorial University, St. John's, Nfld.; Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
出版信息
CMAJ. 2020 Jul 6;192(27):E768-E777. doi: 10.1503/cmaj.190814.
Abstract
摘要
相似文献
1
Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.慢性胃食管反流病患者食管腺癌筛查指南
CMAJ. 2020 Jul 6;192(27):E768-E777. doi: 10.1503/cmaj.190814.
2
Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC).慢性胃食管反流病患者（有或无其他危险因素）的食管腺癌和癌前病变（异型增生和巴雷特食管）筛查：两项系统评价和一项综述评价，为加拿大预防保健特别工作组（CTFPHC）指南提供信息。
Syst Rev. 2020 Jan 29;9(1):20. doi: 10.1186/s13643-020-1275-2.
3
[Pathogenesis and epidemiology of Barrett esophagus].[巴雷特食管的发病机制与流行病学]
Chirurg. 1994 Feb;65(2):84-7.
4
Adiposity and columnar-lined esophagus.肥胖与柱状上皮化生食管
Am J Gastroenterol. 2008 May;103(5):1316-7. doi: 10.1111/j.1572-0241.2007.01782_9.x.
5
Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.胃食管反流、巴雷特食管与食管癌：科学综述
JAMA. 2002 Apr 17;287(15):1972-81. doi: 10.1001/jama.287.15.1972.
6
Management of Barrett's esophagus: cases and questions.巴雷特食管的管理：病例与问题
Semin Oncol. 2005 Dec;32(6 Suppl 9):S2-5. doi: 10.1053/j.seminoncol.2005.06.006.
7
Current challenges in Barrett's esophagus.巴雷特食管目前面临的挑战。
Cleve Clin J Med. 2001 May;68(5):415-7, 422-4. doi: 10.3949/ccjm.68.5.415.
8
Cardiac mucosa indicates risk for Barrett esophagus.心脏型黏膜提示巴雷特食管风险。
World J Gastroenterol. 2006 Aug 28;12(32):5259. doi: 10.3748/wjg.v12.i32.5259.
9
Clinical biology of the Barrett's metaplasia, dysplasia to carcinoma sequence.巴雷特化生、发育异常至癌变序列的临床生物学。
Surg Oncol. 2001 Nov;10(3):91-102. doi: 10.1016/s0960-7404(01)00030-5.
10
Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.胃食管反流病、巴雷特食管和食管腺癌。
Arch Intern Med. 2004 Jul 26;164(14):1482-8. doi: 10.1001/archinte.164.14.1482.
引用本文的文献
1
A Canadian algorithm for upper gastrointestinal cancer management.一种用于上消化道癌症管理的加拿大算法。
Front Oncol. 2025 Apr 14;15:1548637. doi: 10.3389/fonc.2025.1548637. eCollection 2025.
2
Evidence summary on management strategies for gastroesophageal reflux symptoms in patients following esophageal cancer surgery.食管癌手术后患者胃食管反流症状管理策略的证据总结
Asia Pac J Oncol Nurs. 2024 Dec 10;12:100639. doi: 10.1016/j.apjon.2024.100639. eCollection 2025 Dec.
3
Efficacy and safety of tegoprazan in the treatment of gastroesophageal reflux disease: A protocol for meta-analysis and systematic review.替戈拉赞治疗胃食管反流病的疗效和安全性：荟萃分析和系统评价方案。
PLoS One. 2024 May 2;19(5):e0302450. doi: 10.1371/journal.pone.0302450. eCollection 2024.
4
Dissemination and implementation of clinical practice guidelines: a longitudinal, mixed-methods evaluation of the Canadian Task Force on Preventive Health Care's knowledge translation efforts.临床实践指南的传播与实施：对加拿大预防保健特别工作组知识转化工作的纵向混合方法评估
CMAJ Open. 2023 Aug 8;11(4):E684-E695. doi: 10.9778/cmajo.20220121. Print 2023 Jul-Aug.
5
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma.肿瘤单核细胞含量可预测食管腺癌的免疫化疗结果。
Cancer Cell. 2023 Jul 10;41(7):1222-1241.e7. doi: 10.1016/j.ccell.2023.06.006.
6
[Not Available].[无可用内容]
Can Fam Physician. 2021 Dec;67(12):e326-e328. doi: 10.46747/cfp.6712e326.
7
Rapid recommendations: Updates from 2020 guidelines: part 1.快速推荐：2020年指南更新：第1部分。
Can Fam Physician. 2021 Dec;67(12):912-914. doi: 10.46747/cfp.6712912.
8
Chronic GERD and risk of esophageal adenocarcinoma: Should we screen with gastroscopy?慢性胃食管反流病与食管腺癌风险：我们应该通过胃镜检查进行筛查吗？
CMAJ. 2020 Jul 6;192(27):E781-E782. doi: 10.1503/cmaj.200697.
本文引用的文献
1
Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC).慢性胃食管反流病患者（有或无其他危险因素）的食管腺癌和癌前病变（异型增生和巴雷特食管）筛查：两项系统评价和一项综述评价，为加拿大预防保健特别工作组（CTFPHC）指南提供信息。
Syst Rev. 2020 Jan 29;9(1):20. doi: 10.1186/s13643-020-1275-2.
2
Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.针对乳腺癌风险未增加的40至74岁女性乳腺癌筛查的建议。
CMAJ. 2018 Dec 10;190(49):E1441-E1451. doi: 10.1503/cmaj.180463.
3
Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.食管腺癌退伍军人中 Barrett 食管筛查和监测的错失机会。
Dig Dis Sci. 2019 Feb;64(2):367-372. doi: 10.1007/s10620-018-5336-5. Epub 2018 Oct 28.
4
Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival.先前诊断出的 Barrett 食管并不常见，但与改善食管腺癌的生存有关。
Dig Dis Sci. 2018 Nov;63(11):3112-3119. doi: 10.1007/s10620-018-5241-y. Epub 2018 Aug 14.
5
Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux.巴雷特食管 3 期临床试验（BEST3）：一项随机对照试验的研究方案，比较 Cytosponge-TFF3 检测与常规护理在初级保健慢性酸反流患者中促进食管前癌诊断的效果。
BMC Cancer. 2018 Aug 3;18(1):784. doi: 10.1186/s12885-018-4664-3.
6
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.埃索美拉唑和阿司匹林在 Barrett 食管（AspECT）中的应用：一项随机析因试验。
Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26.
7
The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.内镜监测对巴雷特食管患者的影响：系统评价和荟萃分析。
Gastroenterology. 2018 Jun;154(8):2068-2086.e5. doi: 10.1053/j.gastro.2018.02.022. Epub 2018 Feb 16.
8
Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.识别用于 Barrett 食管非内镜检测的 DNA 甲基化生物标志物。
Sci Transl Med. 2018 Jan 17;10(424). doi: 10.1126/scitranslmed.aao5848.
9
Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia.勘误：美国胃肠病学会（ACG）和美国临床肿瘤学会（CAG）消化不良管理临床指南。
Am J Gastroenterol. 2017 Sep;112(9):1484. doi: 10.1038/ajg.2017.238. Epub 2017 Aug 1.
10
The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival.巴雷特食管先前诊断对食管腺癌生存率的影响。
Am J Gastroenterol. 2017 Aug;112(8):1256-1264. doi: 10.1038/ajg.2017.82. Epub 2017 Apr 4.
Zotero 插件